Introduction
Lineage-restricted transcription factors regulate differentiation of hematopoietic progenitors by promoting lineage-specific transcriptional programs and simultaneously repressing the transcriptional profile of alternative lineages. PU.1, C/EBPα and C/EBPβ are transcription factors that regulate neutrophil differentiation from progenitors 1 .
Deletion of either gene leads to the absence of neutrophils in conjunction with variable alterations of eosinophils, lymphocytes and monocytes.
Growth factor independence 1 (Gfi1) is a zinc-finger transcription factor first identified as a gene frequently targeted for proviral integration contributing interleukin-2 growth independence in a rat lymphoma cell line and promoting T-cell lymphoma development [2] [3] [4] . Gfi1 is expressed in thymus, spleen, testis, and the hematopoietic system 2, 5 . In hematopoietic stem cells, Gfi1 maintains quiescence 6, 7 . In myeloid cells, Gfi1 promotes differentiation 5, 8, 9 . Gfi1-null mice lack normal neutrophils and accumulate a population of atypical Gr1 + /CD11b + cells that share characteristics of neutrophils and macrophages, and can mature into macrophages but not neutrophils 5, 8 .
The mice are small, die prematurely of bacterial infections, and have reduced T and B cell differentiation 5, 8, 10 . Rare cases of severe congenital neutropenia have been linked to heterozygous Gfi1 mutations, which can act as dominant negative 11 9 . The patients resemble Gfi1-null mice in displaying neutropenia, abnormal circulating myeloid precursors, and reduced B and T lymphocytes 9 .
Previous studies have concluded that Gfi1 regulates myeloid cell maturation by transcriptional repression of target genes, including suppressor of cytokine signaling 3 (SOCS3) 12 , neutrophil elastase 13 , colony stimulating factor1 (CSF1)/CSF1 receptor 11 ,
For personal use only. on October 31, 2017 . by guest www.bloodjournal.org From 4 and the microRNAs miR-21 and miR-196b 14 . Derepression of these genes explains important aspects of defective neutrophil differentiation in Gfi1-null mice and patients with Gfi1 mutations. Gfi1 can bind consensus DNA target sequences via a C-terminal zinc-finger domain and repress transcription via its N-terminal SNAG domain 15 , in part by recruiting co-repressors [16] [17] [18] [19] . Besides acting as a transcriptional repressor, Gfi1
interacts with the protein PIAS3, which can bind to and inhibit STAT3 signaling 20 . As a result, Gfi1 can relieve STAT3 from PIAS3-induced inhibition, resulting in enhanced STAT3 signaling. Since STATs are activated by a variety of cytokines and growth factors, we hypothesized that Gfi1 could play a role as a modulator of cytokine and growth factor responses.
We focused on G-CSF and its unique receptor (G-CSFR), which are critical to the generation of neutrophils from granulocyte/monocyte precursors and their release to the peripheral circulation. Homozygous deletion of G-CSFR or G-CSF causes severe neutropenia in mice 21, 22 , and heterozygous mutations of G-CSFR have been linked to sporadic cases of severe congenital neutropenia 23 . As both Gfi1 transcriptional regulation and G-CSF/G-CSFR signaling are critical to neutrophil maturation, we have investigated whether their activities might be linked. We find that Gfi1 functions as a regulator of G-CSF/G-CSFR signaling in myeloid cells by promoting expression of RasGRP1 (Ras guanine nucleotide releasing protein1), which is shown to be a critical modulator of G-CSF/G-CSFR-induced Ras activation.
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Methods

Mice and cell isolation
Germline Gfi1-/-mice 24 were bred and housed in the NCI animal facilities. Genotyping was as described 24 . All animal studies were approved by the NCI Bethesda Animal Care and Use Committee and were carried out per protocol with mice 4-8 weeks of age. G-CSF induced cell mobilization experiments were described 25 . Bone marrow, thymic and splenic cell suspensions were prepared from isolated organs by standard techniques.
Peripheral blood cell counts and differentials were carried out by the NIH Clinical Center using an ADVIA 120 hematology System (Bayer). 
Cell culture
Retroviral constructs, infection and siRNA
Gfi1-GFP-RV and GFP-RV 26 and pBabe-RasGRP1 or pBabe 27 were previously constructed. Retroviruses were packaged in the Phoenix packaging cell line, as described 28 . Two-day culture supernatants were filtered, supplemented with Polybrene (4mg/ml, final concentration; Sigma) and used for infection. Two days after infection with Gfi1-GFP-RV and GFP-RV retroviruses, GFP-expressing 32D cells were sorted; only cell populations at least 80% GFP-positive were used for experiments. Two days after infection with pBabe-RasGRP1 or pBabe retroviruses, Puromycin (1mg/ml) was added to 32D cells for selection. For infection of primary mouse bone marrow cells, a similar method was applied except for the use of RetroNectin TM -coated plates (Takara), and cell pre-culture (18-72hr) in culture medium supplemented with IL-3 (10ng/ml), cKitL (25ng/ml), SCF (25ng/ml), and GM-CSF (5ng/ml). Two days after retroviral infection, the GFP-positive and-negative cells were sorted and the cells used for further experiments. RasGRP1 was silenced with small interfering RNAs (siRNAs) for mouse RasGRP1 (Ambion, Applied Biosystems); risc-free siRNA (Dharmacon) was used as control. siRNA was transfected into 32D cells using Amaxa nucleofector system (Amaxa Biosystems) optimized for 32D cells (E-32), with Cell Line Nucleofector Solution V.
Transfection efficiency was assessed by GFP-positivity. 
RNA isolation, semi-quantitative and real-time PCR
Statistical analysis
Group differences were evaluated by 2-tailed Student t test. P values less than 0.05 were considered significant.
Results
Altered G-CSF signaling in Gfi1-deficient hematopoietic cells
Consistent with previous studies, Gfi1-null mice from our colony have a reduction in circulating granulocytes (Supplementary Table 1 ) and in the mobilization response to G-CSF administration in vivo (Supplementary Table 2 ), deficiencies that could derive from defective G-CSF responses.
G-CSF signals through the G-CSFR, which is expressed exclusively from myeloid-restricted progenitor cells to mature neutrophils 30 . We found G-CSFR expression levels to be reduced by ~50% in bone marrow mononuclear cells (MNC) from
Gfi1-null mice in comparison to control WT and heterozygous mice, with or without G-CSF stimulation in vitro (Fig. 1A ). Since G-CSFR expression increases with myeloid cell differentiation 30 , reduced G-CSFR expression in Gfi1-null bone marrow MNC is likely due to the reduction in neutrophils.
To assess G-CSFR function, we measured G-CSF-induced cell proliferation, which excludes the non-dividing neutrophils; as a control for G-CSF, we used IL-3. In all cases, IL-3 was a stronger inducer of proliferation than G-CSF, likely reflecting the wider distribution of IL-3 as opposed to G-CSF receptors in bone marrow cells. G-CSF induced proliferation in bone marrow MNC from all mice, including Gfi1-/-mice, indicating that the G-CSFR is functional in Gfi1-null bone marrow MNC (Fig. 1B) .
Noteworthy, G-CSF promoted greater proliferation in MNC from Gfi1-/-mice compared to +/+ and +/-controls, likely attributable to the absence of neutrophils in Gfi1-/-bone marrows and the relative enrichment of immature cells with greater proliferative potential (Fig. 1B) . However, when G-CSF-induced signaling was examined (Fig. 1C, D ), Erk1/2
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From phosphorylation was found reproducibly reduced in Gfi1-/-bone marrow MNC, whereas STAT1, STAT3, and p38MAPK phosphorylation was similar. STAT5 phosphorylation was also somewhat lower in Gfi1-/-bone marrow MNC compared to controls. We tested whether expression of Gfi1 in Gfi1-/-bone marrow MNC could reconstitute Erk1/2 activation by G-CSF. Using a retroviral vector for expression of GFP-Gfi1 and sorting the GFP-positive and negative cell populations, we found that expression of Gfi1 in Gfi1-/-bone marrow MNC reconstituted Erk1/2 phosphorylation in a proportion of cells stimulated with G-CSF (Fig. 1E ).
To identify signaling alterations underlying defective G-CSF activation of Erk in
Gfi1-null bone marrow MNC, we queried a number of pathways linked to G-CSFR activation or Erk1/2 activation ( Fig. 1E and not shown). MEK1/2 phosphorylation (Ser217/221), which is upstream of Erk1/2 and contributes to G-CSF-induced myeloid cell differentiation 31 , was not induced by G-CSF stimulation in bone marrow MNC from Gfi1-/-mice, but was induced in MNC from +/+ controls ( Fig. 1F ). By contrast, we detected a similar degree of basal Src activity (phosphorylation of tyrosine (Tyr) 416 in bone marrow MNC of Gfi1+/+ and -/-mice, which was not modulated by G-CSF stimulation (Fig. 1F ). SOCS3, a negative regulator of G-CSF signaling that was reported expressed at higher levels in progenitor cells from Gfi1-/-mice 12 , was detected at similarly low levels in bone marrow MNC from Gfi1 +/+ and -/-mice (not shown).
Phosphorylated (serine (Ser) 359) MKP1 (mitogen-activated protein kinase phosphatase-1) and Akt (Ser473) were also detected at similarly low levels in bone marrow MNC from Gfi1-/-and +/+ mice, with or without G-CSF (not shown).
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To explore whether there might be a global defect in Erk1/2 signaling, we stimulated bone marrow MNC with IL-3, which activates the Erk1/2 pathway through the IL-3 receptor, a receptor that is functional in most nucleated hematopoietic cells 32 .
However, bone marrow MNC from Gfi1+/+, +/-and -/-mice similarly activated Erk1/2 phosphorylation with 10ng/ml IL-3 ( Fig. 2A) , which was a stronger activator of Erk1/2 than G-CSF (Fig. 2B) , presumably reflective of the wider expression of IL-3-responsive cells in bone marrow MNC.
The defect in MEK1/2 and Erk1/2 phosphorylation following G-CSF stimulation of bone marrow MNC from Gfi1-/-mice suggested that Ras activation might be impaired in these cells. Consistent with this possibility, a pull-down assay of active Ras (using agarose-bound GST-Raf1 residues 1-149, corresponding to the Raf1 domain that binds to
Ras-GTP) detected significantly greater amounts of active Ras (constitutive and G-CSFinduced) in bone marrow cell lysates from +/+ in comparison to -/-mice (Fig. 2C, representative results), differences (both constitutive and G-CSF-induced) that were not attributable to a Ras protein deficiency in the bone marrow cell lysates from Gfi1-/-mice (Fig. 2C) . Also, consistent with active Ras serving as an inducer of the Raf-MEK-Erk pathway, reduced Ras-GTP was accompanied by reduced phospho-Erk1/2 in Gfi-/-cells (Fig. 2C ).
RasGRP1 deficiency in Gfi1-deficient mice
To identify genes whose expression might underlie the defective Ras activation in Gfi1-null mice, we used microarray analysis to compare patterns of gene expression in bone marrow MNC from Gfi1-/-and +/+ mice. Among the genes whose expression differed
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From by at least 5-fold, we found that RasGRP1 (Ras guanine nucleotide releasing protein1) mRNA was about 8-fold less abundant in bone marrow MNC from Gfi1-/-mice compared to +/+ controls. RasGRPs are Ras guanine nucleotide-exchange factors (Ras GEFs) that positively regulate Ras activity by catalyzing the release of GDP, allowing Ras binding to cellular GTP 33 . By real-time PCR, we confirmed that levels of RasGRP1 mRNA were reduced in the bone marrow MNC of Gfi1-/-mice compared to +/+ and +/-mice (Fig. 3A) . In the thymus and spleen, where RasGRP1 mRNA is substantially more abundant than in bone marrow, levels of RasGRP1 mRNA were also reduced in Gfi1-/-mice compared to controls (Fig. 3A) . This difference in RasGRP1 mRNA was confirmed at the protein level in the thymus and spleen by immunoprecipitation/immunoblotting (Fig. 3B ). Consistent with the low level of mRNA in bone marrow (Fig. 3A) , RasGRP1 protein was not clearly detected in bone marrow cell lysates even from wild type mice (Fig. 3B) . Nonetheless, RasGRP1 mRNA was consistently detected in bone marrow MNC from +/+ and +/-mice and to a significantly (P<0.05) lower degree in Gfi1-/-mice (Fig. 3C) .
By flow cytometry, we identified in the bone marrow MNC of control mice a small (0.5-3.0%) population of cells with intracellular RasGRP1, which was not found in the Gfi1-null mice (representative results Fig. 3D ). These cells expressing RasGRP1 displayed a high SSC (side scattering counter) (Fig. 3E ) and low surface Gr1 expression (Fig. 3F ), characteristics compatible with immature granulocytic precursors 34 . By double staining, the RasGRP1-expressing cells did not stain for the neutrophil marker 7/4, the monocyte/macrophage marker CD11b, the T-cell marker CD4, the pan-B cell marker CD45R/B220, or the hematopoietic cell progenitor marker cKit; most of the cells (Fig. 3G ).
Further analysis showed that the RasGRP1-expressing cells were found within the CMP and GMP cell populations (Fig. 3H) .
We sorted bone marrow MNC that exhibited high SSC and low or high level Gr1 expression. Consistent with previous observations 5 , FSC (forward scattering counter) and SSC of bone marrow MNC from Gfi1-/-mice differed from that of +/+ mice in showing a reduction of cells with high SSC and intermediate FSC (Fig 4A) . Consistent with their defective neutrophil maturation, Gfi1-null mice showed a reduction in the Gr1 hi cell population and an expansion of Gr1 lo cell population (Fig. 4A , right panels). Within the Gr1 lo cell population from +/+ mice, we identified cells that specifically stained brightly with RasGRP1 mAb (Fig. 4B) . However, no RasGRP1-staining cells were identified within the Gr1 lo cell population from -/-mice (Fig. 4B ). RasGRP1 staining was mostly confined to the plasma membrane/cytoplasm, and the cells that stained for
RasGRP1 displayed the nuclear morphology of immature cells (Fig. 4B-D) . No
RasGRP1-brightly positive cells were identified within the more mature myeloid cells, based on nuclear morphology (DAPI and Giemsa staining) and Gr1 hi expression (Fig.   4B,C) .
Gfi1 regulates RasGRP1 expression and signaling
To test for the possibility that Gfi1 may induce RasGRP1 expression and that RasGRP1 deficiency may contribute to defective G-CSF signaling and function in Gfi1-/-mice, we stably transduced the murine myeloid 32D cells with rat Gfi1 or rat RasGRP1 retroviral vectors, as these cells do not constitutively express detectable levels of Gfi1 or RasGRP1
For (Fig. 5A) . Forced expression of Gfi1 in these cells was accompanied by increased expression of endogenous RasGRP1 mRNA (Fig. 5B, C) , but not G-CSFR (not shown), and increased phosphorylation of Erk1/2 with G-CSF, but not IL-3 (Fig. 5D) .
Conversely, silencing RasGRP1 in Gfi1-transduced 32D cells resulted in decreased phosphorylation of Erk1/2 with G-CSF, but not IL-3 (Fig. 5E ). In addition, overexpression of RasGRP1 in 32D cells resulted in increased phosphorylation of Erk1/2 upon stimulation with G-CSF, but less clearly with IL-3. By contrast, RasGRP1 expression in 32D cells was accompanied by minimal change in G-CSF-induced activation of STAT3 and STAT5 (Fig. 5F) , and expression of G-CSFR (not shown).
G-CSF can stimulate Gfi1 expression in 32D cells under culture conditions that promote their terminal differentiation into neutrophils 6, 25 . We now found that G-CSF additionally stimulates expression of endogenous RasGRP1 in 32D cells after the induction of Gfi1 (Fig. 5G) . Thus, Gfi1 promotes expression of RasGRP1 in 32D cells, which specifically enhances Erk1/2 phosphorylation in response to G-CSF.
RasGRP1 promotes G-CSF-dependent neutrophil differentiation from hematopoietic progenitor cells
Upon withdrawal of IL-3 and addition of G-CSF, 32D cells differentiate from myeloblasts into more mature granulocytic cells over a period of days. We examined whether forced RasGRP1 expression led to increased 32D cell differentiation with G-CSF. Staining with DAPI distinguishes the nuclei of myeloblasts from those of more mature myeloid cells, based upon the absence of cavitation, lobulation, or fragmentation (Fig. 6A) . In kinetic experiments, we found that RasGRP1-transduced 32D cells (Fig. 6A) . Gfi1-transduced 32D cells showed differentiation kinetics similar to those of RasGRP1-transduced cells (Fig. 6A) .
After a 4-day incubation with G-CSF, granulocytic differentiation was consistently greater in Gfi1-or RasGRP1-transduced 32D cells compared to controls (P<0.05; Fig.   6B ). Thus, functionally, Gfi1 and RasGRP1 similarly support G-CSF-induced granulocytic differentiation of 32D cells.
Since the transient expression of Gfi1 in Gfi1-null granulocyte progenitors partially corrected the defect in neutrophil differentiation and promoted generation of mature neutrophils 5 , we tested the effects of RasGRP1 expression in these assays. By using a retroviral vector for expression of RasGRP1 and puromycin selection, we increased relative RasGRP1 expression in Gfi1-/-bone marrow MNC by 3-to 4-fold (Fig. 6C ). When transduced with RasGRP1 and stimulated with G-CSF, Gfi1-/-bone marrow cells activated Erk1/2, albeit to a somewhat lower degree than control Gfi1+/+ cells, whereas Gfi1-/-bone marrow cells transduced with the empty retroviral vector essentially failed to do so (Fig. 6D ).
Colony assays in semisolid medium supplemented with IL-3, IL-6 and SCF revealed an increase in progenitors responsive to these cytokines from Gfi1-/-bone marrow cells compared to +/+ control, a difference that persisted when the cells were transduced with RasGRP1 (Fig. 6E) . Most (>90%) of the colonies from the Gfi1-/-control and RasGRP1-transduced cells were CFU-M, and the remainder (<10%) were CFU-GM. By contrast, the colonies from the Gfi1+/+ precursors were 50% CFU-G, 39%
CFU-M and the remaining 11% were CFU-GM. Colony assays in semisolid medium supplemented with G-CSF also showed an increase in progenitors responsive to this
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From cytokine from Gfi1-null bone marrow cells compared to +/+ control (Fig. 6F) . Virtually all the colonies from Gfi1+/+ precursors were CFU-G, whereas virtually all the colonies from Gfi1-/-vector-transduced precursors were CFU-M. Instead, 30-50% of colonies from Gfi1-/-cells transduced with RasGRP1 were CFU-G, and the remainder CFU-M.
Importantly, microscopic analysis of G-CSF-induced colonies (cytospin preparations) from Gfi1-null cells transduced with RasGRP1 revealed the presence of clusters of cells at different stages of granulocyte differentiation, including mature neutrophils, which were generally missing from control Gfi1-null bone marrow cells (not shown). To confirm that introduction of RasGRP1 in Gfi1-/-bone marrow cells promoted neutrophil differentiation, we utilized liquid cultures supplemented with G-CSF. After a 4-day incubation, we counted mature neutrophils in cytospin preparations. In three experiments, we found that expression of RasGRP1 in Gfi1-/-bone marrow cells promoted substantial neutrophil differentiation in the presence of G-CSF (P<0.05 vector vs RasGRP1), which was largely missing from control cultures (Fig. 6G) . Thus, introduction of RasGRP1 corrects, at least in part, the defect in neutrophil differentiation resulting from the loss of Gfi1.
Discussion
The interplay between transcription factors and cytokines/growth factors that regulate differentiation of myeloid cells from hematopoietic precursors remains largely undefined.
Individually, the transcription factor Gfi1 and the cytokine G-CSF are critical regulators of neutrophil maturation from granulocyte/monocyte progenitors. Here we show that the transcription factor Gfi1 regulates G-CSF signaling through the Ras-MEK-Erk pathway, . Since we observed that RasGRP1 is expressed at abnormally low levels in thymus and spleen of Gfi1-null mice, it is possible that RasGRP1 deficiency may also contribute to the T and B-cell deficiencies in Gfi1-deficient mice and patients 5, 8, 10 . Previously, the monopoietic cytokine CSF-1 (colony stimulating factor-1/M-CSF) 11 , the transcription factor PU.1
42
, and the microRNAs miR21 and miR-196b 14 were
reported to contribute to defective myelopoiesis in Gfi1-null mice. It is not surprising that defective granulopoiesis in the context of Gfi1 deficiency is multifactorial.
Consistent with this possibility, granulopoiesis from Gfi1-null precursors was only partially reconstituted by neutralization of CSF-1 11 , heterozygosity at the PU.1 locus 42 , silencing miR21 and miR-196b 14 , and transduction of RasGRP1, shown here.
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Thus far, transcriptional repression of target genes has been identified as a principal mechanism of Gfi1 function as a regulator of granulopoiesis. This has contributed to models in which commitment to granulopoiesis is a default pathway 1 .
Here we find evidence that Gfi1 can stimulate the expression of RasGRP1 and induce 
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